The Association of International Normalized Ratio with Postoperative Complications in Revision Total Knee Arthroplasty

Abstract

The purpose of this study was to examine the relationship between elevated preoperative international normalized ratio (INR) and (1) mortality, (2) postoperative bleeding, and (3) other postoperative complications in a national cohort of patients who underwent revision total knee arthroplasty (rTKA). The American College of Surgeons National Surgical Quality Improvement Program was queried for rTKA procedures conducted between 2006 and 2017. Cohorts were based on INR ranges: <1, 1 < INR ≤ 1.25, 1.25 < INR ≤ 1.5, and >1.5. Univariate/multivariate statistics were calculated to analyze associations between INR value and designated covariates. These statistics were additionally applied to optimal cutoff values of INR calculated using a receiver operating characteristics curve. The final cohort consisted of 1,676 patients. Progressively higher INR values were associated with an increased risk of mortality within 30 days (p < 0.006), bleeding requiring transfusion (p < 0.001), sepsis (p < 0.001), return to the operating room (Odds Ratio [OR], p = 0.011), reintubation (p < 0.001), pneumonia (p < 0.001), failure to wean from mechanical ventilation ≤48 hours (p < 0.001), acute renal failure (p = 0.001), and hospital length of stay (LOS). Statistically significant associations were similarly seen when calculated optimal INR values were used. Optimal INR turn point was found to be associated with a significant increased risk of long LOS (optimal INR = 1.03, OR: 1.7, 95% confidence interval [CI]: 1.33–2.18; p < 0.001) and a significant decreased risk of bleeding requiring transfusion (INR = 1.005, OR: 0.732, 95% CI: 0.681–0.786; p < 0.001). High preoperative INR values were independently and significantly associated with an increased risk of multiple postoperative complications. Current guidelines for INR <1.5 should be reassessed for patients undergoing rTKA.

Keywords

international normalized ratio - revision total knee arthroplasty - postoperative - complications - outcomes

Publikationsverlauf

Eingereicht: 07. August 2019

Angenommen: 18. September 2019

Artikel online veröffentlicht:
07. November 2019

• References

• 1 van Veen JJ, Spahn DR, Makris M. Routine preoperative coagulation tests: an outdated practice?. Br J Anaesth 2011; 106 (01) 1-3
• 2 AAOS. Preventing VTE in patients undergoing elective hip and knee arthroplasty. AAOS 2011148. Accessed October 16, 2019 at: https://www.aaos.org/research/guidelines/VTE/VTE_full_guideline.pdf
• 3 Ignjatovic V. Prothrombin time/international normalized ratio. Methods Mol Biol 2013; 992: 121-129
• 4 Tamim H, Habbal M, Saliba A. et al. Preoperative INR and postoperative major bleeding and mortality: a retrospective cohort study. J Thromb Thrombolysis 2016; 41 (02) 301-311
• 5 Hshieh TT, Kaung A, Hussain S, Curry MP, Sundaram V. The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage. Saudi J Gastroenterol 2015; 21 (04) 254-258
• 6 Sølbeck S, Ostrowski SR, Johansson PI. A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients. Thromb J 2012; 10 (01) 5
• 7 Rudasill SE, Liu J, Kamath AF. Revisiting the international normalized ratio (INR) threshold for complications in primary total knee arthroplasty: an analysis of 21,239 cases. J Bone Joint Surg Am 2019; 101 (06) 514-522
• 8 Segal JB, Dzik WH. Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45 (09) 1413-1425
• 9 Mont MA, Jacobs JJ, Boggio LN. et al; AAOS. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 2011; 19 (12) 768-776
• 10 Rhodes DA, Severson EP, Hodrick JT, Dunn HK, Hofmann AA. Discontinuation of warfarin is unnecessary in total knee arthroplasty. Clin Orthop Relat Res 2010; 468 (01) 120-126
• 11 Wallace DL, Latimer MD, Belcher HJCR. Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg [Br] 2004; 29 (03) 203-205
• 12 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
• 13 Ehlert BA, Nelson JT, Goettler CE. et al. Examining the myth of the “July Phenomenon” in surgical patients. Surgery 2011; 150 (02) 332-338
• 14 American College of Surgeons National Surgical Quality Improvement Program “Quality Improvement through Quality Data”. Accessed October 16, 2019 at: https://www.facs.org/-/media/files/quality-programs/nsqip/nsqip_puf_userguide_2017.ashx
• 15 Bradley AE. The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recognition 1997; 30 (07) 1145-1159
• 16 Wingert NC, Gotoff J, Parrilla E, Gotoff R, Hou L, Ghanem E. The ACS NSQIP risk calculator is a fair predictor of acute periprosthetic joint infection. Clin Orthop Relat Res 2016; 474 (07) 1643-1648
• 17 Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med (Zagreb) 2016; 26 (03) 297-307
• 18 Cohn MR, Levack AE, Trivedi NN. et al. The hip fracture patient on warfarin: evaluating blood loss and time to surgery. J Orthop Trauma 2017; 31 (08) 407-413
• 19 Aguilera X, Videla S, Almenara M, Fernandez JA, Gich I, Celaya F. Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Orthop Belg 2012; 78 (01) 68-74
• 20 Huff TW, Sculco TP. Management of bone loss in revision total knee arthroplasty. J Arthroplasty 2007; 22 (07) (Suppl. 03) 32-36
• 21 Shon O-J, Lee D-C, Ryu SM, Ahn HS. Comparison of difference in hematologic and hemodynamic outcomes between primary total knee arthroplasty and revision of infected total knee arthroplasty. Knee Surg Relat Res 2016; 28 (02) 130-136
• 22 Jasper LL, Jones CA, Mollins J, Pohar SL, Beaupre LA. Risk factors for revision of total knee arthroplasty: a scoping review. BMC Musculoskelet Disord 2016; 17 (01) 182
• 23 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
• 24 Nelson CL, Elkassabany NM, Kamath AF, Liu J. Low albumin levels, more than morbid obesity, are associated with complications after TKA. Clin Orthop Relat Res 2015; 473 (10) 3163-3172